Cynata Therapeutics Health Care
Cancer Healthcare

$0.125 (0%)

High $0.13	Low $0.12	Trades 20	Turnover $48,049	Volume 400,697
30 June 2023 at 3:57pm

Market Cap (3-Aug) $3,164,906 (1,053rd)	Close (30-Jun) $0.125 0 (0%)	Volume (30-Jun) 400,697	Shortsold (13-May) 3,127 (0.00%) (661st)
52w High $0.435	52w Low $0.011	P/E -	EPS -0.04
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 1+

Short Interest

ASIC data, 13 May 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

661st

of 710 shorted ASX stocks

Peak Short

0.63%

Nov 2024

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	CYP CYP Ann: Cynata to Present at MST Access Investor Conference 15 June
	1 (current) 2 3
	CYP CYP Ann: Cynata signs Licence Agreement with TekCyte
	CYP CYP Ann: Release of Securities from Voluntary Escrow
	CYP CYP Ann: First Patient Enrolled in Cynata MEND Clinical Trial
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Cynata Expands trial in COVID-19 & Respiratory Failure
	CYP CYP Ann: Cynata Investor Presentation
	CYP CYP Ann: New Study to Investigate the High Potency of Cymerus MSCs
	CYP CYP Ann: Cynata Advances Planned Clinical Trial in DFU with TekCyte
	CYP CYP Ann: Appendix 4D & Half-Year Financial Statements
	CYP CYP Ann: Cynata Receives $1.39m R&D Tax Incentive Refund
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Cleansing Notice
	CYP CYP Ann: Appendix 2A
	CYP CYP Ann: Completion of Entitlement Offer and Shortfall Placement
	CYP CYP Ann: Entitlement Offer Closing Date Reminder
	CYP CYP Ann: Cleansing Notice
	CYP CYP Ann: Appendix 2A
	CYP CYP Ann: 2020 Review and Outlook
	CYP CYP Ann: Becoming a substantial holder
	CYP CYP Ann: Cleansing Notice
	CYP CYP Ann: Appendix 2A
	CYP CYP Ann: Letter to Ineligible Shareholders
	CYP CYP Ann: Offer Booklet and Entitlement & Acceptance Form
	CYP CYP Ann: Cynata Entitlement Offer Opens
	CYP CYP Ann: Cleansing Notice
	CYP CYP Ann: Cynata provides update on Placement and Appendix 2A
	CYP CYP Ann: Letter to Optionholders
	CYP CYP Ann: Notice Under Section 708AA of the Corporations Act
	CYP CYP Ann: Investor Presentation
	CYP CYP Ann: Proposed issue of Securities - CYP
	CYP CYP Ann: CYP Closes $15m Institutional Placement to Expand Pipeline
	CYP CYP Ann: Trading Halt
	CYP CYP Ann: Appendix 3Ys x 5
	CYP CYP Ann: Appendix 3G
	CYP CYP Ann: Replacement Constitution
	CYP CYP Ann: Results of Annual General Meeting
	CYP CYP Ann: AGM Presentations
	CYP CYP Ann: Cynata Technology Featured on Front Cover of Nature Medicine
	CYP CYP Ann: Phase 3 Osteoarthritis Clinical Trial Commences
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: AusBiotech Conference Presentation
	CYP CYP Ann: Annual Report to Shareholders
	CYP CYP Ann: Letter to Shareholders, Notice of AGM & Proxy Form
	CYP CYP Article: 'It had the smell of Lehman Brothers'
	CYP CYP Article: Alium ups stake in Emerald Clinics in upcoming IPO
	CYP CYP Article: The interview questions these 28 Australian CEOs always ask ...
	CYP CYP Article: Markets Live: Financials plummet on euro concerns

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
03-Aug	$0.01	746,414	+0.00 (8.33%)
31-Jul	$0.01	52,608	0.00 (0.00%)
30-Jul	$0.01	395,525	0.00 (0.00%)
29-Jul	$0.01	959,313	0.00 (0.00%)
28-Jul	$0.01	2,544,000	+0.00 (9.09%)
27-Jul	$0.01	377,166	0.00 (8.33%)
24-Jul	$0.01	862,739	0.00 (7.69%)
23-Jul	$0.01	237,697	0.00 (0.00%)
22-Jul	$0.01	264,829	0.00 (0.00%)
21-Jul	$0.01	231,813	+0.00 (8.33%)
20-Jul	$0.01	609,663	0.00 (0.00%)
17-Jul	$0.01	6,408,384	-0.18 (93.68%)
18-Sep	$0.19	484,918	0.00 (0.00%)
12-Sep	$0.19	52,293	-0.01 (2.56%)
11-Sep	$0.20	289,331	+0.01 (2.63%)
4 up, 4 down, and 7 flat days

Cynata Therapeutics Health Care Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Cynata Therapeutics Health Care
Cancer Healthcare